Косметика өндірісі мен технологиясына кіріспе
жүктеу/скачать 16,24 Mb. Pdf көрінісі
|
b436ce0a649361871333ff7a454fb4e8 original.17032999
| Arch Dermatol Res
. 1997;289(7):404 – 409. 56. Deprez, P.: Textbook of Chemical Peels. Superficial, Medium, and Deep Peels in Cosmetic Practice , London: Informa UK, 2007. 57.
Abbott, S.: How the ‘stuff’ in formulations impacts the delivery of actives. Cosmet Toi- letries . 2013;128(2):116 – 123. 58.
Williams, A.: Transdermal and Topical Drug Delivery: From Theory to Clinical Practice , London: Pharmaceutical Press, 2003. 59.
Draelos, Z. D.: Eczema Regimens, In: Drealos, Z. D., ed.: Cosmetic Dermatology Prod- ucts and Procedures , Hoboken: Wiley-Blackwell, 2010. 60. Müller, R. H., Dingler, A.: The next generation after the liposomes: solid lipid nano particles (SLN ® ,
Eurocosmetics . 1998;7/8:19 – 26. 61. Geusens, B., Van Gele, M., Braat, S., et al.: Flexible nanosomes (SECosomes) enable efficient siRNA delivery in cultured primary skin cells and in the viable epidermis of ex vivo human skin. Adv Funct Maters . 2010;20:4077 – 4090. 62.
Malhotra, M., Jain, N. K.: Niosomes as drug carriers. Indian Drugs . 1994;31:81 – 86. 63. Udupa, N.: Niosomes as Drug Carriers, In: Jain, N. K.: Controlled and Novel Drug Deliv- ery , 1st Edition, New Delhi: CBS Publishers and Distributors, 2002. 64.
de Vringer, T., de Ronde, H. A.: Preparation and structure of a water-in-oil cream con- taining lipid nanoparticles. 222 J Pharm Sci . 1995;84(4):466 – 472. 65. Sivaramakrishnan, R.: Glucocorticoid entrapment into lipid carriers – characterization by parelectric spectroscopy and influence on dermal uptake. J Control Release . 2004;97(3):493 – 502. 66. Müller, R. H., Petersen, R. D., Hommoss, A., et al.: Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev . 2007;59:522 – 530. 67. Loo, C. H., Basri, M., Ismail, R., et al.: Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion. Int J Nanomedicine . 2013;8:13 – 22. 68. Raschke, T., Koop, U., Dusing, H. J., et al.: Topical activity of ascorbic acid: from in vitro optimization to in vivo efficacy. Skin Pharmacol Physiol . 2004;17:200 – 206. 69. Fluhr, J. W., Vienne, M. P., Lauze, C., et al.: Tolerance profile of retinol, retinalde- hyde, and retinoic acid under maximized and long-term clinical conditions. Dermatol . 1999;199S:57 – 60. 70. Bissett, D. L.: Common cosmeceuticals. Clin Dermatol . 2009;27:435 – 445. 71. Matsuda, S., Shibayama, H., Hisama, M., et al.: Inhibitory effects of novel ascorbic derivative VCP-IS-2Na on melanogenesis. Chem Pharm Bull . 2008;56:292 – 297. 72. Slavin, J. W.: Considerations in alpha hydroxy acid peels. Clin Plastic Surg . 1998;25:4 – 52. 73. Foldvari, M., Attah-Poku, S., Hu, J., et al.: Palmitoyl derivatives of interferon alpha: potent for cutaneous delivery. жүктеу/скачать 16,24 Mb. Достарыңызбен бөлісу:
|